TD Ameritrade Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,088
| Closed | -$10K | – | 603 |
|
|
2023
Q1 | $10K | Sell |
1,088
-234
| -18% | -$2.15K | ﹤0.01% | 381 |
|
|
2022
Q4 | $12K | Sell |
1,322
-304
| -19% | -$2.76K | ﹤0.01% | 372 |
|
|
2022
Q3 | $13K | Sell |
1,626
-1,118
| -41% | -$8.94K | ﹤0.01% | 364 |
|
|
2022
Q2 | $21K | Buy |
2,744
+404
| +17% | +$3.09K | ﹤0.01% | 379 |
|
|
2022
Q1 | $22K | Buy |
2,340
+588
| +34% | +$5.53K | ﹤0.01% | 410 |
|
|
2021
Q4 | $14K | Buy |
1,752
+1,359
| +346% | +$10.9K | ﹤0.01% | 454 |
|
|
2021
Q3 | $4K | Buy |
+393
| New | +$4K | ﹤0.01% | 539 |
|
|
2020
Q4 | – | Sell |
-393
| Closed | -$4K | – | 660 |
|
|
2020
Q3 | $4K | Hold |
393
| – | – | ﹤0.01% | 539 |
|
|
2020
Q2 | $5K | Buy |
+393
| New | +$5K | ﹤0.01% | 517 |
|
|
2019
Q2 | – | Sell |
-528
| Closed | -$8K | – | 680 |
|
|
2019
Q1 | $8K | Buy |
528
+51
| +11% | +$773 | ﹤0.01% | 387 |
|
|
2018
Q4 | $7K | Buy |
477
+254
| +114% | +$3.73K | ﹤0.01% | 410 |
|
|
2018
Q3 | $5K | Buy |
223
+161
| +260% | +$3.61K | ﹤0.01% | 406 |
|
|
2018
Q2 | $2K | Buy |
+62
| New | +$2K | ﹤0.01% | 381 |
|